0.3752
price down icon1.19%   -0.0045
after-market 시간 외 거래: .38 0.0048 +1.28%
loading
전일 마감가:
$0.3797
열려 있는:
$0.3753
하루 거래량:
736.51K
Relative Volume:
0.56
시가총액:
$22.22M
수익:
-
순이익/손실:
$-41.95M
주가수익비율:
-0.452
EPS:
-0.83
순현금흐름:
$-38.34M
1주 성능:
-0.90%
1개월 성능:
-1.68%
6개월 성능:
-47.25%
1년 성능:
-87.02%
1일 변동 폭
Value
$0.3701
$0.3755
1주일 범위
Value
$0.3633
$0.388
52주 변동 폭
Value
$0.221
$3.09

Elevation Oncology Inc Stock (ELEV) Company Profile

Name
명칭
Elevation Oncology Inc
Name
전화
(716) 371-1125
Name
주소
101 FEDERAL STREET, BOSTON
Name
직원
34
Name
트위터
Name
다음 수익 날짜
2025-03-05
Name
최신 SEC 제출 서류
Name
ELEV's Discussions on Twitter

ELEV을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ELEV
Elevation Oncology Inc
0.3752 22.43M 0 -41.95M -38.34M -0.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
463.27 123.14B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
550.00 60.43B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.69 42.07B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
572.71 34.47B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
290.35 27.42B 3.81B -644.79M -669.77M -6.24

Elevation Oncology Inc Stock (ELEV) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-24 다운그레이드 Stephens Overweight → Equal-Weight
2025-03-21 다운그레이드 Citizens JMP Mkt Outperform → Mkt Perform
2025-03-21 다운그레이드 Leerink Partners Outperform → Market Perform
2025-03-21 다운그레이드 Piper Sandler Overweight → Neutral
2025-01-03 개시 William Blair Outperform
2024-05-31 개시 Piper Sandler Overweight
2024-05-14 개시 Stephens Overweight
2024-03-01 개시 JMP Securities Mkt Outperform
2023-05-30 업그레이드 SVB Securities Market Perform → Outperform
2021-12-23 개시 H.C. Wainwright Buy
모두보기

Elevation Oncology Inc 주식(ELEV)의 최신 뉴스

pulisher
Jul 16, 2025

what makes elevation oncology inc. stock price move sharplyFree Stock Market Swing Trading Strategies - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Elevation Oncology Inc. stock attracts strong analyst attentionHigh Reward Risk Balanced Trading - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Elevation Oncology Inc. stock performs during market volatilityMulti Bagger Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Elevation Oncology Inc. stock price move sharplyChart Based Entries - Newser

Jul 15, 2025
pulisher
Jul 04, 2025

Elevation Oncology Terminates EO-3021 Study Amid Implications for Future Research and Development Strategies - AInvest

Jul 04, 2025
pulisher
Jul 03, 2025

EO-3021 Study Termination: Implications for Elevation Oncology and Partners - TipRanks

Jul 03, 2025
pulisher
Jul 02, 2025

Elevation Oncology Terminates License Agreement with CSPC - TipRanks

Jul 02, 2025
pulisher
Jun 30, 2025

Elevation Oncology, Inc. (NASDAQ:ELEV) Receives $3.39 Average PT from Brokerages - Defense World

Jun 30, 2025
pulisher
Jun 17, 2025

Analyzing Ratios: Elevation Oncology Inc (ELEV)’s Financial Story Unveiled - DWinneX

Jun 17, 2025
pulisher
Jun 16, 2025

Elevation Oncology, Inc. (NASDAQ:ELEV) Sees Large Decline in Short Interest - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, ELEV, MTWO, CRKN on Behalf of Shareholders - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 14, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 14, 2025
pulisher
Jun 13, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTCCRKN), Elevation Oncology, Inc. (NasdaqELEV), Sitio Royalties Corp. (NYSESTR), Vigil Neuroscience, Inc. (NasdaqV - TradingView

Jun 13, 2025
pulisher
Jun 13, 2025

Research Analysts Set Expectations for ELEV FY2025 Earnings - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Q2 Earnings Estimate for ELEV Issued By Leerink Partnrs - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Equities Analysts Issue Forecasts for ELEV Q3 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Wedbush Forecasts Reduced Earnings for Elevation Oncology - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Elevation Oncology (NASDAQ:ELEV) Cut to “Hold” at TD Cowen - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

HC Wainwright Downgrades Elevation Oncology (NASDAQ:ELEV) to Neutral - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Stock Rating Lowered by HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Downgraded by HC Wainwright to Neutral - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Receives Market Perform Rating from JMP Securities - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Lowered to Hold Rating by William Blair - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology’s (ELEV) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc.ELEV - Business Wire

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology (ELEV) Receives Analyst Rating Update | ELEV Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

This McDonald's Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology (ELEV) Receives Downgrade from HC Wainwright & Co. | ELEV Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

TD Cowen Downgrades Elevation Oncology to Hold From Buy - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

HC Wainwright Downgrades Elevation Oncology to Neutral From Buy - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology (ELEV) Downgraded by H.C. Wainwright Amid Mer - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology agrees to be acquired by Concentra - The Pharma Letter

Jun 10, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Acquires 41,215 Shares of Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Millennium Management LLC Boosts Stock Holdings in Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Elevation Oncology agrees to Concentra Biosciences buyout By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology (ELEV) Downgraded Following Acquisition News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology (ELEV) Downgraded by William Blair Following Acquisition Announcement | ELEV Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology (ELEV) to be Acquired by Concentra Biosciences | ELEV Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Concentra to acquire Elevation in bid to eliminate another biotech ‘zombie’ - BioPharma Dive

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology Accepts a Buyout Offer from Concentra Biosciences - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Concentra Biosciences, LLC entered into a definitive merger agreement to acquire Elevation Oncology, Inc. for $21.4 million. - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

ELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. Is Fair to Shareholders - Business Wire

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology stock soars on Concentra merger agreement By Investing.com - Investing.com Nigeria

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology stock soars on Concentra merger agreement - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Concentra buys out another struggling Boston biotech - The Business Journals

Jun 09, 2025

Elevation Oncology Inc (ELEV) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$22.01
price up icon 0.64%
$35.47
price down icon 0.37%
$104.17
price down icon 0.40%
$27.63
price down icon 2.26%
$111.04
price down icon 1.29%
biotechnology ONC
$290.35
price up icon 4.01%
자본화:     |  볼륨(24시간):